研究单位：[1]Cancer Center, Sun Yat-sen University[2]Cancer Institute and Hospital, Chinese Academy of Medical Sciences[3]Sichuan Cancer Hospital and Research Institute[4]Fujian Cancer Hospital[5]Fudan University[6]Cancer Hospital of Guizhou Province[7]First Affiliated Hospital of Guangxi Medical University[8]Central South University
This is an open, multicenter phase Ⅱ clinical trial on cetuximab (C225) combined with IMRT + concurrent chemotherapy of cisplatin in locoregionally advanced nasopharyngeal carcinoma.
